Interdisciplinary Council in Chita: New Standards for Women's Health in the Russian Federation
On May 21, a major conference with gynecologists and oncologists was held, dedicated to the treatment of reproductive organ tumors and HPV. Doctors discussed patient management tactics and improving access to medical care in the Far East.
Interdisciplinary Council in Chita: When Federal Strategy Meets Far Eastern Reality
What looks like a routine regional event is actually a public alignment between the federal center and a territory where the demographic problem has taken on the scale of national security
I have been analyzing medical policy and trends in women's health for over a decade. And the conference in Chita on May 21, 2026, is not "just another event." It is the moment when three key documents converged at one point, and the meeting hall of the Chita State Medical Academy became a mirror of the systemic problems of the Far East.
Let's look at what is hidden between the lines of the official program.
[The Essence]: What Is Really Happening
On May 21, 2026, the Chita State Medical Academy hosted the XIII Conference of Obstetricians-Gynecologists, Oncologists, Dermatovenerologists of the Trans-Baikal Territory with All-Russian Participation, titled "Women's Health in the 21st Century: From Menarche to Menopause."
Organizers: Chita State Medical Academy, Trans-Baikal Society of Obstetricians-Gynecologists, Association of Physicians "Trans-Baikal Medical Chamber," Ministry of Health of the Trans-Baikal Territory. 188 physicians in person and online. Dozens of reports. Clinical case reviews. One interdisciplinary council.
But here's what matters. The conference was held as part of the implementation of two documents:
- "National Strategy for Action in the Interests of Women for 2023-2030" (approved December 29, 2022)
- "Strategy for Demographic Policy of the Far East for the Period up to 2030 and for the Future up to 2036" (approved February 2, 2026)
The date of the second document is critical: only 3.5 months before the conference. This is not a "traditional event." It is the first large-scale public review of how the federal strategy will be implemented on the ground.
Chronology and Context
Let's build the chain of events that was not in the news headlines.
November 2025 – January 2026: The Government of the Russian Federation approves a new procedure for providing medical care in the field of obstetrics and gynecology, which comes into force on January 10, 2026. The document introduces changes to the work of women's health clinics, perinatal centers, and reproductive health centers. The key innovation is pre-abortion counseling by a psychologist or a specially trained medical worker.
February 2026: President of the Russian Federation Vladimir Putin gives instructions following a meeting of the Council for the Implementation of State Demographic and Family Policy. The government is tasked with conducting federal statistical observations of "reproductive plans of the population" at least once every three years starting from 2026.
March 2026: The Ministry of Health updates methodological recommendations for medical check-ups to assess reproductive health. The main change: the test for high-risk HPV is moved to the first stage of the check-up (previously it was the second stage). Women aged 21 to 49 are examined once every 5 years. Cytology (liquid-based) is performed only if the HPV test is positive.
Why is this important? Because the new scheme completely changes the logic of cancer screening. Previously, cytology was taken first (every 3–5 years), then HPV if suspicions arose. Now, the virus is sought first. And only if it is present are cells examined. This is a cheaper (PCR is cheaper than cytology) and more sensitive strategy. But it requires a laboratory infrastructure that does not exist in the Far East.
April 2026: The Government of the Russian Federation obliges regions to organize free transportation to doctors for pregnant women from remote settlements. Prime Minister Mikhail Mishustin personally comments on this change in the compulsory medical insurance program.
May 2026 (21st): Conference in Chita.
Who Wins and Who Loses
Winner: The federal demographic security agenda.
Numbers you haven't seen. At the meeting of the Government Commission on the Development of the Far East on January 26, 2026, Deputy Prime Minister of the Russian Federation Yuri Trutnev directly stated that the macro-region continues to face a shortage of qualified medical personnel and low accessibility of care in remote settlements.
At the same time, since 2018, within the framework of the "presidential Far Eastern unified subsidy," 80 hospitals have been built and modernized, and more than 50 feldsher-obstetric points have been opened. The programs "Zemsky Doctor" and "Zemsky Feldsher" are in effect.
And here is the key figure: since 2024, when calculating the compulsory medical insurance subvention for the Far East, an increasing coefficient of medical care accessibility of 1.5 has been applied, which will provide an additional 11.2 billion rubles already in 2026.
It is this budget that allows holding such conferences, implementing new screening protocols, and building perinatal centers. By 2030, it is planned to equip 11 perinatal centers, create 7 women's health clinics, and renovate 56 facilities in ten regions of the Far Eastern Federal District.
Winner (but more complex): Chita State Medical Academy.
Chita State Medical Academy is not just a venue. It is the main beneficiary of federal funds in Trans-Baikal. The academy trains personnel who then leave under the "Zemsky Doctor" programs. And the more conferences, the higher the academy's status in the eyes of the Ministry of Health and the more funding.
But there is a flip side to this coin. The report by the Chief Freelance Specialist of the Ministry of Health of the Russian Federation in the Far Eastern Federal District for obstetrics, gynecology, and women's reproductive health, Professor T.E. Belokrinitskaya, was titled "Tumors of Female Reproductive Organs in the Far Eastern Federal District: Problems and Solutions." Not "achievements." "Problems." The very wording is telling.
Losers: Women in remote areas of Trans-Baikal and the Far Eastern Federal District.
And here we come to the main contradiction. The new screening strategy—first HPV, then cytology—requires a laboratory infrastructure. PCR diagnostics for HPV must be performed in accredited laboratories.
In Chita—available. In Krasnokamensk, Nerchinsk, Balei—not available.
A woman from the village of Ugolnye Kopi (Chukotka), where a new diagnostic and treatment building with CT and expert-class ultrasound was opened in May 2026, is relatively okay. But a woman from a village with a population of 300, which is a three-hour drive off-road in a UAZ vehicle? Her PCR test will be taken by a feldsher to the district hospital, then to Chita. The result will come back in two to three weeks.
This is what the phrase "improving access to medical care" really means.
What the Media Are Not Saying
Insight #1: The conference in Chita is not about Chita. It is about the gap between Khabarovsk and Moscow.
In February 2026, the Governor of Khabarovsk Krai, Dmitry Demeshin, signed a new regional program of state guarantees for free medical care for 2026-2028. The total budget is 57.23 billion rubles (an increase of 4.36 billion rubles compared to last year).
The program explicitly states: for women aged 21-49, a comprehensive examination for early diagnosis of cervical cancer risks will now be provided free of charge once every five years. That is, what the Ministry of Health has established at the federal level, Khabarovsk Krai is already funding from its own budget.
And Trans-Baikal? And Chukotka? And Sakhalin? They have different budgets. And different capabilities.
The conference in Chita is a public acknowledgment that the gap between Far Eastern regions in access to women's health is enormous. Khabarovsk and Primorye are relatively well-off. Trans-Baikal, Buryatia, Chukotka are problem areas. And the only way to fix this is interdisciplinary interaction. Not because it is "fashionable," but because there are simply no other tools.
Insight #2, the most important: "Pre-abortion counseling" and "reproductive intentions" are euphemisms. The real topic is demographic pressure on doctors.
Since January 10, 2026, according to the new medical care procedure, pre-abortion counseling is conducted by a psychologist or a specially trained medical worker. If a pregnant woman decides to keep the child, she is counseled throughout the pregnancy and after childbirth.
In the check-up questionnaires, there is now a question about the desired number of children "taking into account your current life circumstances." If the answer is "zero"—a consultation with a psychologist.
Formally—care for the woman. Practically—the doctor finds themselves between the patient and the state demographic policy.
The Chairman of the State Duma Committee on Health Protection, Sergey Leonov, clarified: this norm is purely advisory, and the decision to visit a psychologist is made by the patient herself.
But in reality, in a small town or village, where the "psychologist" is the same obstetrician-gynecologist who completed two-week courses, pressure will be felt. Especially if the doctor has target indicators for "pregnancy preservation."
At the conference in Chita, of course, this was not spoken aloud. But all the doctors present know it. And they remain silent.
Forecast: The Next 30 Days and 90 Days
30 days: Publication of methodological recommendations based on the council's outcomes.
After the conference, practical recommendations for doctors in the Trans-Baikal Territory will be issued. The main focus is the algorithm for managing HPV-positive patients (when to refer for cytology, how often to monitor). Without this algorithm, the new screening scheme will not work—doctors simply will not know what to do with a positive test.
90 days: Report from the Ministry of Health of Trans-Baikal on the accessibility of medical care.
By August 2026, the regional Ministry of Health must present a report on the implementation of the demographic policy strategy. The key indicator is the number of women who have completed the full cycle of "HPV test → cytology → treatment (if necessary)." If this figure is below 50% of those who underwent check-ups, organizational conclusions will follow.
Third scenario: A wave of criticism of the "new screening model" from the medical community.
There is already non-public resistance. Doctors say: "Before, we took cytology from everyone and slept peacefully. Now we first look for HPV. And if the PCR test gives a false negative result (and it does, sensitivity is not 100%), the woman will leave without examination with a clean HPV but with CIN 2-3?"
This is a risky strategy. And if in the coming months there is even one high-profile case of missed cervical cancer due to the "new protocol," the conference in Chita will resurface as the place where this strategy was officially adopted.
Business takeaway for those reading between the lines: Look at manufacturers of PCR systems for HPV diagnostics (Russian "DNA-Technology," "NextBio," foreign Roche, Abbott). The market for HPV tests in Russia will grow by 30-40% in 2026 due to the shift of the test to the first stage of check-ups. But the main growth will begin when regions massively purchase laboratory equipment for remote areas—and that will not happen before 2027.
And if you are just a woman in Trans-Baikal or any other region of Russia—get a check-up. The HPV test is now free and done at the first stage. A positive result is not a death sentence. It is a reason to have cytology. A negative result—peace of mind for five years.
And remember: the doctor at the women's health clinic is not an enemy or a tool of state policy. They are just a person with a medical degree and endless paperwork. Ask them why the new protocol is exactly like this. The answer will surprise you. Or it won't—if you have read this article to the end.
— Editorial Team
